Long-term survival following post-allograft relapse of T-cell acute lymphoblastic leukaemia: a novel approach using nelarabine and donor lymphocyte infusions.

Burley, K; Wolf, J; Raffoux, E; Marks, D I

Burley, K; Wolf, J; Raffoux, E; Marks, D I.

Affiliation

Burley K; Department of Haematology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. kate.burley@bristol.ac.uk.
Wolf J; Department of Haematology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Raffoux E; Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, Paris, France.
Marks DI; Department of Haematology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Bone Marrow Transplant ; 53(3): 344-346, 2018 03.

Article in En | MEDLINE | ID: mdl-29269798

Subject(s)

Arabinonucleosides/therapeutic use; Lymphocyte Transfusion/methods; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/therapy; Survivors; Adult; Humans; Male; Recurrence; Transplantation, Homologous; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arabinonucleosides / Survivors / Lymphocyte Transfusion / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Limits: Adult / Humans / Male Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2018 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google